Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Argus Health
Chubb
Mallinckrodt
Accenture
Citi
Teva
Medtronic
Farmers Insurance

Generated: July 22, 2018

DrugPatentWatch Database Preview

Chlorothiazide sodium - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for chlorothiazide sodium and what is the scope of chlorothiazide sodium freedom to operate?

Chlorothiazide sodium
is the generic ingredient in two branded drugs marketed by Fresenius Kabi Usa, Luitpold, Mylan Institutional, Sagent Pharms, Sun Pharma Global, and Oak Pharms Akorn, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are forty-two drug master file entries for chlorothiazide sodium. Six suppliers are listed for this compound.
Pharmacology for chlorothiazide sodium
Ingredient-typeThiazides
Drug ClassThiazide Diuretic
Physiological EffectIncreased Diuresis
Synonyms for chlorothiazide sodium
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide, monosodium salt
6-Chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide, 1,1-dioxide, monosodium salt
7085-44-1
C7H5ClN3O4S2.Na
CHEMBL1200616
Chlorothiazide sodium (USP)
Chlorothiazide sodium [USAN:USP]
Chlorothiazide sodium [USAN]
CPIWHAFLBZQYLQ-UHFFFAOYSA-N
D03471
Diuril sodium
DTXSID00221091
EINECS 230-387-3
HE061402
HE382052
LS-176845
Lyovac diuril
SN86FG7N2K
SODIUM 6-CHLORO-1,1-DIOXO-7-SULFAMOYL-2H-1??,2,4-BENZOTHIADIAZIN-2-IDE
Sodium diuril
UNII-SN86FG7N2K

US Patents and Regulatory Information for chlorothiazide sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional CHLOROTHIAZIDE SODIUM chlorothiazide sodium INJECTABLE;INJECTION 202493-001 Jun 18, 2014 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Luitpold CHLOROTHIAZIDE SODIUM chlorothiazide sodium INJECTABLE;INJECTION 202561-001 Apr 22, 2013 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sagent Pharms CHLOROTHIAZIDE SODIUM chlorothiazide sodium INJECTABLE;INJECTION 202462-001 May 29, 2015 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Oak Pharms Akorn DIURIL chlorothiazide sodium INJECTABLE;INJECTION 011145-005 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
QuintilesIMS
Merck
Accenture
US Army
Johnson and Johnson
Cantor Fitzgerald
Daiichi Sankyo
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.